The goal of this prospective implementation study is to understand the impact of a blood-based screening test (BBST) for colorectal cancer (CRC) on patient acceptability of and adherence to CRC screening as well as the rate of follow-up BBST in those with negative BBST at a 1-year interval.
Additional aims include assessing the impact of digital patient navigation intervention on the rate of follow-up colonoscopy in individuals with positive BBST. Patients will be randomized into the non-intervention arm or the intervention with an app arm.
patients aged 45-84 years of age
Considered by health-care providers to be "average risk" for CRC as determined by USPSTF guidelines
If a patient opts for BBST, they are able and willing to provide blood samples per protocol
Ability to understand and the willingness to participate in the study
Patients with a personal history of CRC
Patients with a known high-risk family history of CRC precluding the patient from being average risk
Patients with known diagnosis of inflammatory bowel disease or history of polyps
Patients who are currently symptomatic for CRC such as: blood in the stool